A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS.

Hu W, Yu Q, Hu N, Byrd D, Amet T, Shikuma C, Shiramizu B, Halperin JA, Qin X. A high-affinity inhibitor of human CD59 enhances complement-mediated virolysis of HIV-1: implications for treatment of HIV-1/AIDS. J Immunol. 2010 Jan 01; 184(1):359-68.

View in: PubMed

subject areas

Acquired Immunodeficiency Syndrome
Bacteriocins
Complement Activation
Complement System Proteins
Flow Cytometry
HIV-1
Humans
Recombinant Proteins

authors with profiles

Cecilia M. Shikuma,MD
Bruce Shiramizu, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support